AVANTOR INC

NYSE: AVTR (Avantor, Inc.)

Last update: 07 Jun, 1:29PM

13.07

0.12 (0.93%)

Previous Close 12.95
Open 13.16
Volume 13,587,258
Avg. Volume (3M) 12,011,580
Market Cap 8,906,290,176
Price / Earnings (TTM) 12.57
Price / Earnings (Forward) 12.77
Price / Sales 1.34
Price / Book 1.47
52 Weeks Range
11.82 (-9%) — 28.00 (114%)
Earnings Date 24 Jul 2025 - 28 Jul 2025
Profit Margin 10.70%
Operating Margin (TTM) 8.21%
Diluted EPS (TTM) 1.04
Quarterly Revenue Growth (YOY) -5.90%
Quarterly Earnings Growth (YOY) 6.80%
Total Debt/Equity (MRQ) 67.34%
Current Ratio (MRQ) 1.12
Operating Cash Flow (TTM) 808.50 M
Levered Free Cash Flow (TTM) 751.08 M
Return on Assets (TTM) 3.53%
Return on Equity (TTM) 12.52%

Market Trend

Short Term Medium Term
Industry Medical Instruments & Supplies (US) Bearish Mixed
Medical Instruments & Supplies (Global) Bearish Bearish
Stock Avantor, Inc. Bearish Bearish

AIStockmoo Score

0.8
Analyst Consensus 1.0
Insider Activity NA
Price Volatility 1.5
Technical Moving Averages 0.0
Technical Oscillators 0.5
Average 0.75

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
AVTR 9 B - 12.57 1.47
BDX 49 B 1.77% 33.25 1.95
RMD 37 B 0.63% 28.24 6.65
WST 16 B 0.37% 34.84 5.86
BLCO 4 B - - 0.680
ALC 43 B 0.36% 38.45 1.94

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

Sector Healthcare
Industry Medical Instruments & Supplies
Investment Style Mid Core
% Held by Insiders 1.32%
% Held by Institutions 103.16%

Ownership

Name Date Shares Held
New Mountain Capital, L.L.C. 31 Mar 2025 14,000,000
52 Weeks Range
11.82 (-9%) — 28.00 (114%)
Price Target Range
14.00 (7%) — 22.00 (68%)
High 22.00 (Wells Fargo, 68.32%) Buy
Median 15.00 (14.77%)
Low 14.00 (Goldman Sachs, 7.12%) Hold
14.00 (Stifel, 7.12%) Hold
Average 16.71 (27.85%)
Total 4 Buy, 3 Hold
Avg. Price @ Call 12.89
Firm Date Target Price Call Price @ Call
Goldman Sachs 29 Apr 2025 14.00 (7.12%) Hold 12.69
Baird 28 Apr 2025 17.00 (30.07%) Buy 12.49
Barclays 28 Apr 2025 15.00 (14.77%) Buy 12.49
10 Apr 2025 18.00 (37.72%) Buy 14.70
Morgan Stanley 28 Apr 2025 15.00 (14.77%) Hold 12.49
RBC Capital 28 Apr 2025 20.00 (53.02%) Buy 12.49
Stifel 28 Apr 2025 14.00 (7.12%) Hold 12.49
Wells Fargo 17 Apr 2025 22.00 (68.32%) Buy 15.10

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria